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Two distinct but related groups of cDNA clones,
CKb4GT-I and CKb4GT-II, have been isolated by screen-
ing a chicken hepatoma cDNA library with a bovine b1,4-
galactosyltransferase (b4GT) cDNA clone. CKb4GT-I is
predicted to encode a type II transmembrane glycopro-
tein of 41 kDa with one consensus site for N-linked gly-
cosylation. CKb4GT-II is predicted to encode a type II
transmembrane glycoprotein of 43 kDa with five poten-
tial N-linked glycosylation sites. At the amino acid level,
the coding regions of CKb4GT-I and CKb4GT-II are
52% identical to each other and 62 and 49% identical,
respectively, to bovine b4GT. Despite this divergence
in amino acid sequence, high levels of expression of
each cDNA in Trichoplusia ni insect cells demonstrate
that both CKb4GT-I and CKb4GT-II encode an a-lactal-
bumin-responsive, UDP-galactose:N-acetylglucosamine
b4-galactosyltransferase.
An analysis of CKb4GT-I and CKb4GT-II genomic
clones established that the intron positions within the
coding region are conserved when compared with each
other, and these positions are identical to the mouse and
human b4GT genes. Thus CKb4GT-I and CKb4GT-II are
the result of the duplication of an ancestral gene and
subsequent divergence. CKb4GT-I maps to chicken
chromosome Z in a region of conserved synteny with the
centromeric region of mouse chromosome 4 and human
chromosome 9p, where b4-galactosyltransferase (EC
2.4.1.38) had previously been mapped. Consequently,
during the evolution of mammals, it is the CKb4GT-I
gene lineage that has been recruited for the biosynthe-
sis of lactose. CKb4GT-II maps to a region of chicken
chromosome 8 that exhibits conserved synteny with hu-
man chromosome 1p. An inspection of the current hu-
man gene map of expressed sequence tags reveals that
there is a gene noted to be highly similar to b4GT lo-
cated in this syntenic region on human chromosome 1p.
Because both the CKb4GT-I and CKb4GT-II gene lin-
eages are detectable in mammals, duplication of the an-
cestral b4-galactosyltransferase gene occurred over 250
million years ago in an ancestral species common to
both mammals and birds.
b1,4-Galactosyltransferase (b4GT; EC 2.4.1.38)1 is a consti-
tutively expressed, trans-Golgi-resident, type II membrane-
bound glycoprotein that catalyzes the transfer of galactose to
N-acetylglucosamine residues, forming the b4-N-acetyllac-
tosamine (Galb4-GlcNAc) or poly-b4-N-acetyllactosamine
structures found in glycoconjugates (1). In mammals, b4GT has
been recruited for a second biosynthetic function, the tissue-
specific production of lactose, which takes place only in the
lactating mammary gland. The synthesis of lactose is carried
out by the protein heterodimer assembled from b4GT and the
noncatalytic protein a-lactalbumin, a mammalian protein ex-
pressed exclusively in lactating mammary epithelial cells (2–
4). Interestingly, b4GT from nonmammalian species such as
chicken (4) and plant (5) can also functionally interact with
a-lactalbumin in vitro, indicating that the a-lactalbumin bind-
ing domain in b4GT predates the rise of mammals.
We have reported that the murine b4GT gene is unusual in
that it specifies two size sets of mRNAs in somatic cells of ;3.9
and ;4.1 kb. These two transcripts arise as a consequence of
initiation at two different sets of start sites that are separated
in the first exon by ;200 bp. Because the respective start sites
are positioned either upstream of the first of two in-frame
ATGs (4.1 kb) or between these two in-frame ATGs (3.9 kb),
translation of each mRNA results in the synthesis of two struc-
turally related, trans-Golgi-resident protein isoforms that dif-
fer only in the length of their NH2-terminal cytoplasmic do-
main (6). The identical structural features are also found in the
bovine (7) and human b4GT gene (8, 9), suggesting that they
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may be a distinguishing characteristic of all corresponding
mammalian b4GT genes.
We have established that murine somatic tissues predomi-
nantly use the 4.1-kb transcriptional start site (10). The only
exception to this general pattern is found in the mid- to late
pregnant and lactating mammary gland, where the 3.9-kb
transcriptional start site is preferentially used. This switch to
the predominant use of the 3.9-kb start site is coincident with
the cellular requirement for increased b4GT enzyme levels in
preparation for lactose biosynthesis. These observations, com-
bined with a detailed promoter analysis, experimentally sup-
port a model of transcriptional regulation in which the region
upstream of the 4.1-kb start site functions as a ubiquitous or
housekeeping promoter for glycan biosynthesis. In contrast,
the region adjacent to the 3.9-kb start site functions primarily
as a mammary cell-specific promoter for lactose biosynthesis
(10, 11). Based on this model, we have argued that the 3.9-kb
transcriptional start site and its accompanying tissue-re-
stricted regulatory elements have evolved in mammals to ac-
commodate the recruited role of b4GT for lactose biosynthesis
(11). One prediction of this model is that, because b4GT in
nonmammalian vertebrates functions exclusively in a house-
keeping (glycan biosynthesis) role, the nonmammalian gene
will exhibit only one (or one set of) clustered transcriptional
start site(s), characteristic of many housekeeping genes. To test
this prediction and to begin to generate a data base for com-
paring the amino acid sequence of b4GT from diverse species to
identify essential amino acids for structure-function correla-
tions, we have isolated and characterized the b4GT gene from
a nonmammalian vertebrate, the chicken.
Based on the isolation of full-length cDNA and genomic
clones and on the expression of enzymatically active recombi-
nant protein, we report that the chicken genome contains two
functional, divergent b4GT genes, termed CKb4GT-I and
CKb4GT-II, and that each encodes an a-lactalbumin-respon-
sive b4GT homologue. CKb4GT-I has been mapped to chicken
chromosome Z in a region of evolutionary conserved synteny
with the centromeric region of mouse chromosome 4 and hu-
man chromosome 9p, where b4-galactosyltransferase had pre-
viously been mapped (12, 13). Consequently, it is the
CKb4GT-I ancestral lineage that has evolved into the mamma-
lian b4GT gene that is recognized to function in lactose biosyn-
thesis. In contrast, CKb4GT-II maps to chicken chromosome 8,
in a region that is syntenic with human chromosome 1p, where
a set of expressed sequence tags, noted to be highly similar to
b4GT, have been mapped. Because both the CKb4GT-I and
CKb4GT-II gene lineages are detectable in mammals, duplica-
tion of the ancestral b4-galactosyltransferase gene occurred
over 250 million years ago in an ancestral species common to
both mammals and birds.
MATERIALS AND METHODS
Reagents—Restriction enzymes, reverse transcriptase, T4 DNA li-
gase, the Klenow fragment of DNA polymerase I, S1 nuclease, and
polynucleotide kinase were from Life Technologies, Inc. or New Eng-
land Biolabs. Taq DNA polymerase was from Boehringer Mannheim.
lgt10 arms and l packaging extracts were from Promega Corp. EcoRI
linkers were from Collaborative Research. Radioactive nucleotides were
from Amersham Corp.
Plasmids and Cell Lines—The chicken MSB-1 and T-249 cell lines
were obtained from Dr. W. Earnshaw (Institute of Cell and Molecular
Biology, University of Edinburgh, Scotland), and grown in Dulbecco’s
modified Eagle’s medium, high glucose supplemented with 10% fetal
calf serum. The MSB-1 cell line is derived from a Marek’s disease
virus-induced lymphoma (15). The T-249 cell line was isolated from a
liver tumor produced by the MC29 strain of avian leukosis virus (16).
Culture media was supplemented with 100 units/ml penicillin and 50
mg/ml streptomycin. The cells were maintained at 37 °C in a 5% CO2
atmosphere.
Construction and Screening of a Chicken Hepatoma cDNA Library—
Double-stranded cDNA, prepared from 10 mg of T-249 poly(A)1 RNA,
was used to construct a lgt10 cDNA library using previously described
procedures (6). Approximately 1 3 106 recombinant phage were
screened using the bovine b4GT cDNA clone 7A as the probe. This clone
contains ;1 kb of coding sequence plus ;300 bp of 39-untranslated
sequence (17).
Construction of Recombinant Transfer Vector and Recombinant
Baculovirus—High Five cells (BTI-TN-5B1–4), derived from Trichop-
lusia ni egg cell homogenates were obtained from Invitrogen, and were
grown in Hanks’ TNM-FH medium (Sera-Lab Ltd, United Kingdom)
supplemented with 10% fetal calf serum (Life Technologies). Linear-
ized, wild-type Autographa californica virus DNA containing a deletion
in an essential viral gene (BaculoGold DNA) was obtained from Pharm-
ingen (San Diego, CA). The plasmid pVT-Bac was kindly donated by Dr.
T. Vernet (Biotechnology Research Institute, Montreal, Canada). This
transfer vector, which contains the signal peptide of the mellitin gene
upstream of a multiple cloning site, was used for the construction of
recombinant plasmids (18).
Plasmid pVT-Bac was digested with BamHI and blunted using T4
DNA polymerase. A 980-bp AvaI fragment from CKb4GT-I cDNA clone
33A, which contains the coding sequence from amino acid residue 45
and includes the stop codon, was blunted with T4 DNA polymerase and
ligated into the vector. Plasmid pVT-Bac was digested with SmaI and
EcoRI and ligated with a 2.2-kb AccI/EcoRI fragment from CKb4GT-II
cDNA clone 25B that contains the coding sequence starting from amino
acid residue 36 and includes the stop codon. Each clone was sequenced
across the junction point.
Recombinant baculovirus was produced as described in the Baculo-
Gold manual supplied by the manufacturer. Infection of T. ni insect
cells with the recombinant virus results in the secretion of a soluble
form of each chicken polypeptide. Cleavage by the signal peptidase
results in one additional amino-terminal residue (Asp) in the polypep-
tide encoded by clone 33A and four additional residues (Asp-Pro-Ser-
Pro) in the polypeptide encoded by clone 25B.
Production of Recombinant Enzyme and Product Characteriza-
tion—T. ni cells were infected at a multiplicity of infection of 5 with
recombinant baculovirus. At 72 h postinfection, the medium was col-
lected and centrifuged to remove detached cells. Galactosyltransferase
assays were carried out directly on aliquots (3–10 ml) of the medium in
a final reaction volume of 50 ml containing 1.25 mmol of GlcNAc as the
acceptor substrate, 5 mmol of Tris-maleate buffer, pH 6.8, 1 mmol of
MnCl2, 0.4 mg of Triton X-100, 200 nmol of ATP, 1 mmol of g-galactono-
1,4-lactone (Sigma), 25 mg of bovine serum albumin, and 25 nmol of
UDP-[3H]Gal (1.1 Ci/mol). The reaction mixtures were incubated at
37 °C for 15 min, and the product was isolated by ion exchange chro-
matography and quantified as described previously (19).
An aliquot of the radioactive product was subjected to high pH anion
exchange chromatography with pulsed amperometric detection. The
system consisted of a Dionex Bio-LC gradient pump, a Carbopac-100
column (4 3 250 mm), and a model PAD 2 detector. The following pulse
potentials and durations were used for detection: E1 5 0.05 V (t1 5 480
ms); E2 5 0.60 V (t2 5 120 ms); E3 5 0.60 V (t3 5 60 ms). Samples were
dissolved in 0.1 M NaOH, and the column was eluted isocratically with
0.1 M NaOH for 10 min, after which a gradient was applied that
increased the concentration of sodium acetate in 0.1 M NaOH by 2.5
mM/min. The flow rate was 1 ml/min. The eluate was collected in 0.5-ml
fractions, and radioactivity was counted in the individual fractions. The
elution position of the radioactive product was compared with that of
the reference compounds: Gal, Galb1,6GlcNAc, Galb1,3GlcNAc, and
Galb1,4Glc, as determined by pulsed amperometric detection.
The effect of a-lactalbumin on the acceptor preference of each recom-
binant enzyme was evaluated by performing the standard galactosyl-
transferase assay as described above, using either GlcNAc or Glc as the
acceptor, in the presence of increasing a-lactalbumin concentrations
(0.1–2.0 mg/ml).
Isolation of Chicken Genomic Clones—A lFIX chicken genomic li-
brary (kindly provided by Dr. C. B. Thompson, Howard Hughes Medical
Institute, University of Chicago) and a chicken cosmid genomic library
(Stratagene) were screened sequentially with the CKb4GT-I and
CKb4GT-II cDNA clones, as described previously (20). The genomic
inserts were characterized by restriction mapping and Southern blot
analysis using exon-specific, 32P-labeled oligonucleotide probes. Specific
genomic restriction fragments were subcloned and partially sequenced
using exon-specific oligonucleotide primers. To subclone the 3.5-kb SstI
and 2.1-kb SstI CKb4GT-I genomic fragments containing exons 1 and 2,
respectively, it was necessary to transform STBL-2 cells (Life Technol-
ogies), which are used to grow clones prone to deletion.
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Northern and Southern Blot Analysis—RNA and DNA were isolated
from T-249 cells by the guanidine isothiocyanate method of Chirgwin et
al. (21). RNA was also isolated from MSB-1 cells and various tissues of
a young female White Leghorn chicken. The isolation of poly(A)1 RNA
and the Northern and Southern blot analyses were carried out as
described previously (17).
S1 Nuclease Analysis—S1 nuclease protection assays were per-
formed as described previously (6). A 656-bp PvuII-NarI CKb4GT-I
genomic DNA fragment was isolated that flanked the anticipated tran-
scriptional start site(s). The NarI cleavage site corresponded to nt 1227
in Fig. 1A. A single-stranded probe complementary to the CKb4GT-I
transcribed sequence was prepared by primer extension of an M13mp18
clone in the presence of [32P]dATP and Klenow polymerase. The probe
contained an additional 87 bp of polylinker sequence. A 305-bp NotI
CKb4GT-II genomic DNA fragment was isolated that spanned the
59-end of the CKb4GT-II sequence and a single-stranded probe, con-
taining 97 bp of polylinker sequence, was prepared as described above.
After purification, probe hybridization to MSB-1 and T-249 RNA was
carried out at 62 °C overnight. The samples were digested with S1
nuclease, and the products were analyzed on a 7% polyacrylamide, 8 M
urea gel.
DNA Sequence and Computer Analyses—Double-stranded, dideoxy-
DNA sequencing was performed using the Sequenase kit from U.S.
Biochemical Corp. The M13, T7, and T3 primers as well as synthetic
oligonucleotides were used as sequencing primers. Oligonucleotides
were synthesized by the Johns Hopkins Core Facility. Sequences were
analyzed using MacVector from International Biotechnologies, Inc. or
the GeneWorks Nucleic Acid and Protein Sequencing Analysis program
from IntelliGenetics, Inc.2
Oligonucleotide Primers—The oligonucleotide primers used to deter-
mine the intron/exon boundaries for the CKb4GT-I genomic clone were
as follows: EX 1F, 59-CCCGGACCGGTCTCGGCAC-39; EX 2F, 59-TAC-
ATGCACCCAATTCTTCA-39; EX 2R, 59-GACCTCAGGGTTTGTGCTC-
GC-39; EX 3F, 59-TACAAGTGCTACAGCCAAC-39; EX 3R, 59-AGCTT-
CCGTGAATCCTACA-39; EX 4F, 59-AAGATCAATGGGTTTCC-39; EX
4R, 59-TGCTCAAGGCAGACACACCTCC-39; EX 5F, 59-TGGGAAATG-
CAGAATGATT-39; EX 5R, 59-TCTGCATTTCCCAATGACAG-39; EX 6R,
59-AGCGAGTTCAAGCCATCAGA-39.
The oligonucleotide primers used to determine the intron/exon
boundaries for the CKb4GT-II genomic clone were as follows: EX 0F,
59-GCCGCGGGAGGAGGTGGC-39; EX 1F, 59-AACACCAACCGCTCC-
GTCAC-39; EX 1R, 59-AAGAGCAACCTGGTCAT-39; EX 2F, 59-CACT-
ACCTGCACCCCATC-39; EX 2R, 59-TCAGGGTTCTCCCGTTGCAC-39;
EX 3F, 59-AACCTGTACCGCTGCTATGA-39; EX 3R, 59-TACTCCTCG-
TCATCCTTCAGC-39; EX 4F, 59-AAGATCAATGGGTTTCC-39; EX 4R,
59-TGCTCAGCCCAGAGACACCTCC-39; EX 5F, 59-ATGGGGAGGTAT-
CGCATGA-39; EX 5R, 59-TCATGCGATACCTCCCCAT-39; EX 6R, 59-T-
GATCCCATCCCGCTTCAT-39.
Localization of CKb4GT-I and CKb4GT-II in the Chicken Genome—
Each CKb4GT gene was mapped using a mismatched primer PCR
approach based on nucleotide substitutions found in either the Jungle
Fowl (JF) or White Leghorn (WL) product (23). To map the b4GT genes,
DNA from 52 progeny of the East Lansing reference population ((JF 3
WL) 3 WL) were used to follow segregation of the JF allele. When base
substitutions were found, 39-mismatched primers were designed to
preferentially amplify only the JF allele. Because the WL is recurrent in
this back-cross, only segregation of the JF can be scored.
PCR primers that initially amplified a region in the second intron of
CKb4GT-I were 59-CAGGTGAGGGGTGCTGAGA-39 (forward) and 59-
AGGCAGTCGTGAAAGAGA-39 (reverse). The 530-bp product was se-
quenced, and an A-G transition was found between JF and WL. A JF
allele-specific 39-mismatched reverse primer, together with the original
forward primer, amplified a 210-bp product; the parental WL allele was
not amplified. PCR primers that initially amplified a region in the
39-untranslated region of CKb4GT-II were 59-CAGACAGAGGGAGGG-
GAC-39 (forward) and 59-AGGGACACGCACACAGCA-39 (reverse). The
410-bp PCR product was sequenced, and an A-G transition was found
between JF and WL. A JF allele-specific 39-mismatched reverse primer,
together with the original forward primer was used to amplify a 257-bp
product; the parental WL allele was not amplified.
RESULTS
Isolation and Characterization of Two Chicken Homologues
of b4GT—The strategy we used to clone chicken b4GT was to
construct a lgt10 nonexpression cDNA library using poly(A)1
RNA isolated from the T-249 cell line and to screen it with our
bovine b4GT cDNA probe. Our choice of T-249 cells for library
construction and the bovine probe for library screening was
based on two considerations. First, by direct enzymatic assay,
T-249 cells exhibited a 3-fold higher level of b4GT activity
compared with MSB-1 cells. Second, Northern blot analysis of
T-249 poly(A)1 RNA revealed a broad hybridization positive
band of ;2.5 kb using the bovine b4GT probe. This latter result
indicated that there was sufficient similarity in the nucleotide
sequence to permit direct screening with the bovine probe.
Approximately 1 3 106 independent recombinants were sub-
sequently screened, resulting in the isolation of 18 cDNA
clones. The six largest inserts were subcloned and partially
sequenced. This preliminary analysis, in combination with par-
tial restriction endonuclease mapping of the other 12 isolates,
revealed the presence of two distinct groups of clones,
CKb4GT-I (nine clones) and CKb4GT-II (nine clones).
Nucleotide Sequence and Translated Amino Acid Sequence of
CKb4GT-I—The complete nucleotide sequence of clone 33A is
shown in Fig. 1A. The first in-frame ATG encoding a long open
reading frame (located at nt 11 to 13) was present in a se-
quence context appropriate for translation initiation (23) and
therefore was designated the initiating Met. The entire 39-
untranslated region (1137 bp) is present in this clone, since a
consensus polyadenylation signal (ATTAAA) is present 15–20
bp upstream of a 21-nt poly(A) tail.
As discussed below, the additional 59-untranslated sequence
(217 to 2210), shown in Fig. 1A, was subsequently obtained
after carrying out S1 analysis on a fragment derived from an
appropriate genomic clone.
The coding region of clone 33A is 66% identical at the nucle-
otide level, and 62% at the amino acid level, to the correspond-
ing bovine sequence. Translation predicts a type II, membrane-
bound, potentially glycosylated protein of 362 amino acids with
an NH2-terminal cytoplasmic domain of 16 amino acids, a
single transmembrane domain of 20 amino acids (assuming
that the Gly residue at position 36 defines the COOH-terminal
boundary of this domain), a stem region of ;55 amino acids,
and a COOH-terminal domain of 271 amino acids. One N-
linked glycosylation consensus site is located at Asn56. The
length of this chicken b4GT homologue is 40 amino acids
shorter than the predicted long protein isoform of bovine b4GT
due to multiple small deletions in the stem region combined
with a cytoplasmic domain that is eight amino acids shorter.
Nucleotide Sequence and Translated Amino Acid Sequence of
CKb4GT-II—The complete nucleotide sequence of CKb4GT-II
(clone 25B) is shown in Fig. 1B. The first in-frame ATG codon
of the longest open reading frame (located at nt 11 to 13) was
assigned as the initiating Met, based on Kozak’s rules for
translation initiation (24) and the fact that an upstream in-
frame termination codon (TGA) is present at nt 2117 to 2115.
Consequently, this cDNA clone contains 209 bp of 59-untrans-
lated sequence plus a coding sequence of 1119 bp. The complete
39-untranslated sequence (1100 bp) is also present in this clone,
since a consensus polyadenylation signal (AATAAA) was lo-
cated 17–22 bp upstream of a 65-nt poly(A) tail.
The coding region is 59% identical at the nucleotide level,
and 49% identical at the amino acid level, to the corresponding
bovine sequence. Translation predicts a type II, membrane-
bound, potentially glycosylated protein of 373 amino acids with
an NH2-terminal cytoplasmic domain of 15 amino acids, a
single transmembrane domain of 18 amino acids, a stem region
of ;64 amino acids, and a COOH-terminal catalytic domain of
276 amino acids. Five N-linked glycosylation consensus sites
are located at Asn50 Asn59, Asn64, Asn87, and Asn358. The
2 The UniGene data base is available through a site on the World
Wide Web at http://www.ncbi.nlm.nih.gov/ (22).
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length of this chicken b4GT homologue is 29 amino acids
shorter than the predicted long protein isoform of bovine b4GT
due to multiple deletions in the stem region, a cytoplasmic
domain that is shorter by nine amino acids, and a six-amino
acid extension at the COOH terminus.
At the nucleotide level, the coding region of CKb4GT-II
(clone 25B) is 61% identical to CKb4GT-I (clone 33A). The
respective 59-untranslated regions that have a GC-content of
;84% were 42% identical; however, a number of gaps were
required to obtain maximal alignment. In contrast, there is
essentially no sequence identity between the respective 39-
untranslated regions.
Northern Blot Analysis—Northern blot analysis was carried
out using RNA isolated from the T-249 cell line, used for cDNA
library construction, to determine the size and number of tran-
scripts corresponding to each cDNA clone. Since the nucleotide
sequence of the coding region of CKb4GT-I and CKb4GT-II is
61% identical, the 39-untranslated region of each transcript
was used to probe the Northern blot. As indicated above, these
regions share no sequence identity.
The CKb4GT-I probe identifies an mRNA species of ;2.5 kb
(Fig. 2A, lane 1). The minor band at ;4.3 kb is due to nonspe-
FIG. 1. Nucleotide and predicted amino acid sequence of CKb4GT-I and CKb4GT-II. The nucleotide sequence is numbered on the left
with sequence upstream of the first in-frame ATG assigned negative numbers. The amino acid sequence is numbered at the right. The 59- and
39-untranslated sequences are in lowercase letters, while the nucleotide sequence corresponding to the coding sequence is in capital letters. The
sequence encoding the putative transmembrane domain is underlined, and the predicted N-linked glycosylation sites are marked with a triple
asterisk below the Asn residues. A, the full-length sequence of CKb4GT-I (clone 33A) is shown, which begins at nt 216. The sequence from 217
to 2210 was obtained after S1 analysis of an overlapping genomic clone. The polyadenylation sequence is underlined and in boldface type. B, the
sequence of CKb4GT-II (clone 25B) is shown with the polyadenylation sequence underlined and in boldface type.
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cific hybridization of the probe to 28 S ribosomal RNA. Since
CKb4GT-I clone 33A (;2.2 kb) contains a consensus poly-
adenylation site and a poly(A) tail, the missing sequence (esti-
mated to be ;150 bp) is from the 59-end.
The CKb4GT-I probe was subsequently removed from the
Northern blot, which was then hybridized with the 39-untrans-
lated region of the CKb4GT-II clone. A single transcript of ;2.5
kb was detected, suggesting that clone 25B represents the
full-length transcript (Fig. 2A, lane 2).
CKb4GT-I and CKb4GT-II Each Encode an Enzymatically
Active, a-Lactalbumin-responsive b4-Galactosyltransferase—
To determine if each chicken cDNA encodes a b1,4-galactosyl-
transferase, constructs were assembled that fused the lumenal
domain of either CKb4GT-I or CKb4GT-II to the signal se-
quence of mellitin. Expression of each cDNA in T. ni insect cells
resulted in the secretion of enzymatically active, soluble en-
zyme. As shown in Table I, both CKb4GT-I and CKb4GT-II
showed a relatively high galactosyltransferase activity using
UDP-Gal as the donor and GlcNAc as the acceptor substrate.
Furthermore, each recombinant galactosyltransferase is able
to interact productively with a-lactalbumin as evidenced by the
production of lactose. When UDP-Gal was replaced by equal
concentrations of UDP-GalNAc, UDP-GlcNAc, or UDP-Glc, the
activity was reduced to less than 1% of that measured with
UDP-Gal. This low level of residual activity was comparable
with that observed with affinity-purified bovine b1,4-galacto-
syltransferase (data not shown).
Since both b1,3- and b1,4-galactosyltransferases have been
detected in chicken, the product formed using GlcNAc as the
acceptor was characterized. On high pH anion exchange chro-
matography, the radioactive product migrated as a single peak,
whose elution position corresponded to authentic Galb1,4GlcNAc
(retention time 7.2 min). No radioactivity was detected at the
elution position of Galb1,3GlcNAc (retention time 10.5 min).
Collectively, these results establish that both CKb4GT-I and
CKb4GT-II encode an a-lactalbumin-responsive UDP-Gal:Glc-
NAc-R b1,4-galactosyltransferase.
Comparison of the Amino Acid Sequences of CKb4GT-I,
CKb4GT-II, and Bovine b4GT—The protein domain structure
established for the cloned mammalian b4-galactosyltrans-
ferases consists of (i) a short NH2-terminal cytoplasmic domain
of 11 or 24 amino acids depending on the protein isoform (6)
and (ii) a large COOH-terminal lumenal domain (;224 amino
acids) containing the catalytic center, linked to a single trans-
membrane domain (20 amino acids) through a potentially gly-
cosylated peptide segment of ;85 amino acids, termed the stem
region. The catalytic domain can be further subdivided into two
distinct structure/function subdomains. (i) The NH2-terminal
region of the catalytic domain contains a 113-amino acid loop
formed by the only intramolecular disulfide bond present in the
protein, between Cys134 and Cys247 (Ref. 25; see bovine se-
quence in Fig. 3, solid arrowheads). This loop plus adjacent
sequence in the stem region (the stem region is defined as the
amino acid sequence between the transmembrane domain and
Cys134) is involved in a-lactalbumin binding as established by
protection studies (26) and antibody blocking studies (27, 28).
(ii) The COOH-terminal 155-amino acid segment contains two
polypeptides, in the vicinity of Cys342 (Fig. 3, bovine sequence),
that can be affinity-labeled with UDP-Gal analogues (26, 29)
or have been implicated in substrate binding by site-directed
mutagenesis (29).
In the context of this domain structure, a comparison of the
amino acid sequence between each chicken b4GT homologue
and a mammalian (bovine) b4GT is interesting (Fig. 3). The
amino acid sequence of CKb4GT-I and CKb4GT-II is 62 and
49% identical, respectively, to the bovine b4GT sequence and
only 52% identical to each other. Thus, CKb4GT-I and
CKb4GT-II are as divergent from each other as they are from
their mammalian counterpart. When the amino acid sequences
of all three proteins are compared, the sequence identity is
reduced to about 42%. The structural domains that are least
conserved are the stem domain and the NH2-terminal region of
the cytoplasmic domain (Fig. 3). Of particular note, six of the
seven Cys residues including the two Cys residues involved in
intramolecular disulfide bond formation (Cys134 and Cys247 in
the bovine sequence, Fig. 3) are conserved in the CKb4GT-I
and CKb4GT-II sequences. The remaining Cys residue (Fig. 3,
open arrowhead) is conserved only in CKb4GT-I; in CKb4GT-
II, this Cys residue is replaced by Tyr. As discussed below, this
fortuitous Cys to Tyr replacement is a useful marker to follow
the evolutionary gene lineage of CKb4GT-I and CKb4GT-II in
the human and mouse genomes.
Southern Blot Analysis and Isolation of CKb4GT-I and
CKb4GT-II Genomic Clones—The comparison of the nucleotide
and amino acid sequence suggested to us that each chicken
homologue is encoded by a separate nonallelic gene that arose
as a consequence of duplication of an ancestral gene followed by
FIG. 2. Northern and Southern blot analysis. A, poly(A)1 RNA (5
mg), isolated from T-249 cells, was resolved by electrophoresis on a
formaldehyde-agarose gel, transferred to Nytran, and probed with a
32P-labeled 830-bp SmaI-EcoRI fragment derived from the 39-untrans-
lated region of CKb4GT-I (lane 1). The minor hybridizing band at 4.3 kb
is due to a low level of 28 S RNA remaining in the poly(A)1 RNA
fraction. After probe removal, the blot was rehybridized with a 32P-
labeled 945-bp PstI fragment derived from the 39-untranslated region of
CKb4GT-II (lane 2). B, genomic DNA (15 mg) isolated from T-249 cells
was digested with BamHI, electrophoresed on an 0.8% agarose gel,
transferred to Nytran, and hybridized with either the 32P-labeled 2.3-kb
insert from clone 3A encoding CKb4GT-I (lane 1) or the SstII-EcoRI
2.3-kb fragment encoding CKb4GT-II (lane 2).
TABLE I
Expression of enzymatically active recombinant
CKb4GT-I and CKb4GT-II in T. ni insect cells
Recombinant CKb4GT-I and CKb4GT-II proteins were produced as
secreted, soluble forms from T. ni insect cells and assayed for enzymatic
activity as detailed under “Materials and Methods.” Based on substrate
preference and product characterization, both the CKb4GT-I and
CKb4GT-II genes encode an a-lactalbumin-responsive, UDP-galactose:
N-acetylglucosamine b4-galactosyltransferase. One unit of enzyme ac-
tivity is defined as the amount of enzyme that catalyzes the transfer of
1 mmol of Gal from UDP-Gal to GlcNAc/min at 37 °C. The indicated
percentages are the relative activities for the indicated assay, based on
the results obtained with GlcNAc as the acceptor in the absence (2) of
a-lactalbumin (a-LA), whose activity was set at 100%.
Transfer to GlcNAc Transfer to Glu
milliunits/ml
CKb4GT-I
a-LA (2) 153.0 (100%) 3.9 (2%)
a-LA (1) 25.0 (16%) 132.0 (86%)
CKb4GT-II
a-LA (2) 28.0 (100%) 1.9 (6%)
a-LA (1) 3.4 (12%) 36.4 (130%)
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divergence. If this is the case, two predictions can be made.
First, Southern analysis should result in two distinct patterns
of restriction fragments. Second, the intron/exon boundaries
within the coding region of each homologue should be identical.
To test the first prediction, a Southern blot containing BamHI-
digested T-249 genomic DNA was hybridized with CKb4GT-I
or CKb4GT-II. As seen in Fig. 2B, CKb4GT-I hybridizes to 7-
and 3.1-kb bands. In contrast, CKb4GT-II hybridizes to 14- and
10-kb bands. This dissimilar pattern confirms that the chicken
genome contains separate genes encoding CKb4GT-I and
CKb4GT-II.
To confirm the second prediction, chicken genomic clones
representing each homologue were isolated and characterized
to determine intron/exon boundaries. A lFIX amplified chicken
genomic library was screened using the CKb4GT-I cDNA
probe; 13 clones (;13 kb), which proved to be identical, were
isolated. Initial characterization including restriction map
analysis, in conjunction with Southern analysis, with probes
from different regions of the coding sequence, established that
the genomic clone (clone 1a), contained sequence limited to
exons 3–6 (Fig. 4A). Consequently, a cosmid library was sub-
sequently screened and two overlapping genomic clones (clones
6b and 14e) of ;40 kb were isolated that contained the missing
upstream sequence.
The lFIX chicken genomic library was also screened with the
CKb4GT-II cDNA probe, and eight overlapping clones were
identified. The longest clone (clone 2a; 14 kb) contained the
entire coding and 39-untranslated sequence, but the majority of
the 59-untranslated sequence was missing (Fig. 4B). The other
seven clones also lacked this sequence. Subsequent screening of
the cosmid library resulted in the isolation of clone 5a (;40 kb),
which contained the missing sequence.
To establish the intron/exon boundaries, subcloned frag-
ments of the genomic clones were sequenced using exon-spe-
cific oligonucleotide primers. Since intron/exon boundaries
within the protein coding region are generally conserved across
species lines, the CKb4GT-I and CKb4GT-II exon-specific
primers used for sequencing were chosen based on the intron/
exon boundaries established for the murine (30) and human
b4GT gene (9). The sequence at the intron/exon boundaries
determined for CKb4GT-I and CKb4GT-II along with the cor-
responding murine sequence is shown in Table II. Based on this
analysis, it is clear that the two chicken b4GT genes share
identical intron/exon boundaries with each other and their
mammalian homologues, an observation that supports the no-
tion of a gene duplication of an ancestral gene. However, unlike
the mammalian b4GT gene, in which the entire 59-untrans-
lated region and first 415 bp of coding sequence are present on
exon 1, the CKb4GT-II gene has one intron within its 59-
untranslated region, positioned at nt 245.
Expression of CKb4GT-I and CKb4GT-II in Various Adult
Chicken Tissues—The presence of two functional b4GT genes
in the chicken would suggest that each is regulated in a tissue-
specific manner. To examine this possibility, a Northern blot
containing poly(A)1 RNA isolated from brain, kidney, liver,
lung, spleen, and pancreas of a female adult chicken was pre-
pared and hybridized sequentially, with a probe derived from
the 39-untranslated region of each clone. As seen in Fig. 5, the
steady state levels of the CKb4GT-II mRNA are significantly
higher in the panel of somatic tissues examined. Somewhat
surprisingly, transcript levels are also high in the brain; this is
in contrast to mice and humans, where b4GT mRNA levels are
about 10-fold lower in the brain as compared with other so-
matic tissues.
FIG. 3. Alignment of the amino acid
sequence of CKb4GT-I, CKb4GT-II,
and bovine b4GT (BOVb4GT). The pre-
dicted amino acid sequences of
CKb4GT-I, CKb4GT-II, and bovine b4GT
are shown. Boxed regions indicate identi-
cal amino acids; dashes indicate intro-
duced gaps. The putative transmembrane
domain of CKb4GT-I (residues 17–36),
CKb4GT-II (residues 16–33), and bovine
b4GT (residues 25–44) is in boldface type
and overlined. The solid arrow denotes
the second in-frame Met14 in bovine
b4GT. The solid arrowheads indicate
Cys134 and Cys247 (bovine sequence),
which form the only intramolecular disul-
fide bond present in the molecule (25).
The open arrowhead indicates Cys342 (bo-
vine sequence) that is replaced by a Tyr in
CKb4GT-II. Note that the second in-
frame Met (Met14 in the bovine sequence),
which serves as the translational start
site for the short b4GT protein isoform, is
not present in either chicken sequence.
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Analysis of the Transcriptional Start Site—Using the rapid
amplification of cDNA ends procedure, attempts to obtain the
;150 bp of sequence estimated to be missing from the 59-
untranslated region of CKb4GT-I clone 33A were unsuccessful,
probably due to the high GC content (84%) of this region.
Therefore, S1 analysis was used as an alternative strategy to
obtain this sequence and simultaneously map the transcrip-
tional start site(s). This strategy was based in part on the fact
that for the mammalian b4GT, the complete 59-untranslated
region (;200 bp) and initial 415 bp of coding sequence are
located on the first exon; consequently, we felt that it was
reasonable to assume that the organization of the 59-end of the
CKb4GT-I gene would be similar.
A single-stranded 656-nt probe, containing genomic se-
quence that spans the 59-end of CKb4GT-I clone 33A, was
hybridized to RNA isolated from MSB-1 and T-249 cells. A
protected product of ;470 bp was observed (data not shown),
showing that the 59-untranslated region of CKb4GT-I is ;210
nt in length and that this entire untranslated sequence is
contiguous with the first 302 bp of coding sequence on exon one.
The length of the protected product (;470 6 20 bp) precludes a
definitive conclusion as to the presence of a single start site or,
alternatively, a set of clustered start sites within this short
;40-bp genomic sequence.
When a single-stranded 402-nt probe containing genomic
sequence that spanned the 59-end of CKb4GT-II was hybrid-
ized to MSB-1 and T-249 RNA, protected products of 165, 175,
190, and 220 bp were observed (data not shown). This result
shows that the CKb4GT-II gene contains a set of closely spaced
clustered start sites spanning ;55 bp. Use of each of these start
sites would yield transcripts with a 59-untranslated region of
210, 220, 235, and 255 nt, respectively; clone 25B represents
the use of the most proximal start site.
Chromosomal Assignment Permits Tracking the CKb4GT-I
and CKb4GT-II Ancestral Lineages in the Human Genome—
b4GT has been cloned from three different mammals: cows,
mice, and humans. From these published reports, only a single
group of cDNA clones with highly conserved coding sequences
(.85%), indicative of a single gene, have been isolated. These
observations, coupled with the identification and characteriza-
tion of two functional a-lactalbumin-responsive b4GT genes in
the chicken genome, which arose as a consequence of duplica-
tion of an ancestral gene, raise two questions. First, which
chicken b4GT gene lineage is the source of the mammalian
b4GT gene that is recognized to function in both glycan biosyn-
thesis and lactose biosynthesis? Second, is there a second func-
tional b4GT gene in the mammalian genome?
A comparison of the respective coding regions of the two
chicken b4GT genes with their mammalian counterpart sug-
gests an answer to the first question. As previously discussed
(Fig. 3), the coding sequence of CKb4GT-I, at the nucleotide
level, exhibits a somewhat greater sequence identity (66%) to
the mammalian (bovine) gene compared with CKb4GT-II
(59%). Based on this analysis, it would appear that the
CKb4GT-I lineage gave rise to the well characterized mamma-
lian b4GT gene that was recruited for lactose biosynthesis.
However, a more definitive approach, based on chromosomal
assignment, can be used to trace the fate of each chicken b4GT
gene lineage in the mammalian (human) genome. This strategy
takes advantage of the comparative gene maps that have been
established between different species, revealing regions of con-
served synteny. These regions define groups of genes that are
located together in close proximity on a chromosome. There-
fore, given the location of a gene in one species, the location in
another can be predicted.
Human b4GT maps to chromosome 9p13 (13) and to the
centromeric region of mouse chromosome 4 (12) in a region that
shows conserved synteny with aconitase. Aconitase also has a
second function, in that it acts as the iron response element-
binding protein (IREBP) (31). In the chicken, aconitase I/
IREBP has been mapped to chromosome Z (32). Using allele-
specific primers, we found that CKb4GT-I maps to chicken
chromosome Z to a region within 2 centimorgans of aconitase
I/IREBP (Fig. 6A). This assignment, then, unequivocally estab-
lishes that the CKb4GT-I gene lineage gave rise to the previ-
ously characterized human and mouse b4GT gene.
We have also mapped the CKb4GT-II gene to chicken chro-
mosome 8. Ribosomal protein L5 (RPL5) also maps to this small
chromosome (33). In the human genome, RPL5 maps to chro-
mosome 1p31–32 (Fig. 6B).3 We have been able to take advan-
tage of the recently established human gene map of expressed
sequence tags (UniGene data base (22) to determine if any
sequence tags, with noted similarity to b4GT, are present on
human chromosome 1p 31–32 near RPL5. In fact, a group of 10
sequence tags (e.g. accession numbers W07207 and AA453005),
which delineate a partial mRNA of ;1.5 kb, have been mapped
to this chromosomal region (Fig. 6B). This ;1.5-kb mRNA has
an open reading frame that encodes a protein of 279 amino
acids that corresponds to about 75% of the coding sequence
(based on the CKb4GT-II coding sequence), including the com-
plete catalytic domain. At the nucleotide and amino acid level,
3 N. Kenmochi, T. S. Kawaguchi, S. Rozen, E. Davis, N. Goodman,
T. Tanaka, and D. C. Page, manuscript in preparation.
FIG. 4. Genomic organization and
partial restriction map of the
CKb4GT-I and the CKb4GT-II gene.
The CKb4GT-I and CKb4GT-II genes are
distributed over 20 and 16 kb of genomic
DNA, respectively. In contrast, the mu-
rine (30) and human (9) b4GT genes span
;50 kb of genomic DNA. Exons, indicated
by the boxes, are numbered 1–6 in agree-
ment with the convention established for
the mammalian b4GT genes (30). Exon 0
represents the additional 59-exon present
in CKb4GT-II. The solid boxes and the
open boxes correspond to the protein cod-
ing sequence and the untranslated se-
quence, respectively. BamHI (B), EcoRI
(E), and SstI (S) sites are shown. The
relative position of each exon within an
indicated SstI fragment is approximate.
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this human b4GT homologue is 77 and 80% identical to
CKb4GT-II, respectively. From an inspection of the primary
sequence, the features suggestive of an UDP-galactose:N-
acetylglucosamine b4-galactosyltransferase are apparent. Spe-
cifically, the relative positions of the four cystinyl residues in
the catalytic domain and the essential amino acids in the two
polypeptides pointed out above that have been affinity-labeled
with UDP-Gal analogues are present (26, 27). Last, at the
position of the Cys342 to Tyr substitution (Fig. 3, open arrow-
head), which distinguishes the respective CKb4GT-I and
CKb4GT-II gene lineages, a Tyr is present. The open question
is whether this human CKb4GT-II homologue on chromosome
1p still encodes an enzymatically active, a-lactalbumin-respon-
sive b4-galactosyltransferase.
DISCUSSION
The unanticipated result from this study was the demonstra-
tion that the chicken genome contains two functional, nonal-
lelic b4GT genes (CKb4GT-I and CKb4GT-II), which encode
distinct a-lactalbumin-responsive, enzymatically active pro-
teins that are only 52% identical (Fig. 3). Based on the conser-
vation of the intron-exon boundaries within the coding region
among CKb4GT-I, CKb4GT-II, and the mammalian b4GT
genes, it is clear that these chicken b4GT genes arose as a
consequence of duplication of an ancestral gene and subse-
quent divergence. When did duplication of the ancestral “b4GT
gene” occur, relative to the independent evolution of mammals
and birds? In considering this question, it is essential to recall
that current opinion holds that mammals and birds last shared
a common ancestor ;250 million years ago.4 Consequently,
depending on the time of the gene duplication, relative to the
divergence from their common ancestor, two different outcomes
can be predicted. First, if duplication of the ancestral b4GT
gene occurred after divergence, it would be anticipated that
these two b4GT genes would be a distinguishing characteristic
of the avian genome and would not be found in the mammalian
genome. In contrast, if the gene duplication took place prior to
the separation of mammals and birds from their common pred-
ecessor, then one would anticipate finding both the CKb4GT-I
and CKb4GT-II gene lineages in the mammalian genome.
As summarized in Fig. 6, we have mapped the CKb4GT-I
gene to chromosome Z, in a region that is syntenic with human
chromosome 9p13, which is the chromosomal location of human
b4GT. Consequently, it can be concluded that it was the
CKb4GT-I gene lineage that was recruited for lactose biosyn-
thesis during the evolution of mammals. Additionally,
CKb4GT-II maps to chicken chromosome 8, in a region that is
syntenic with human chromosome 1p, and where a set of ex-
pressed sequence tags with noted similarity to b4GT has re-
cently been mapped. Thus, both the CKb4GT-I and CKb4GT-II
lineages can be detected in the mammalian genome, indicating
that duplication of the ancestral b4GT gene occurred at least
250 million years ago, prior to the divergence of mammals and
avians from their common ancestor.
The Human Genome Contains Additional CKb4GT-II-re-
lated Genes—Interestingly, four additional sets of expressed
sequence tags with noted similarity to b4GT were also noted in
the UniGene data base. Three sets map to human chromo-
somes 1q21-23, 3q13, and 18q11, respectively. The fourth set of
expressed sequence tags has not yet been assigned a chromo-
somal position. From the available coding sequence, it is clear
that three of these additional human b4GT-related genes en-
code a type II protein with a coding sequence that is ;40%
identical with each other and with mouse or human b4GT.2
(For the fourth set of sequence tags, mapped to 18q11, only the
C-terminal 120 amino acids have been reported). An inspection
of their primary sequence reveals that the relative positions of
the six cystinyl residues are also conserved. Last, at the posi-
tion of the Cys342 to Tyr substitution (Fig. 3, open arrowhead),
which distinguishes the respective CKb4GT-I and CKb4GT-II
lineages, a diagnostic Tyr is present in each of the additional
homologues. Consequently, it would appear that these four
additional human b4GT homologues have arisen from multiple
duplications within the CKb4GT-II gene lineage.
Multiple mouse expressed sequence tags with noted similar-
ity to b4GT have also been deposited in the dbEST data bank.
Unfortunately, these mouse sequence tags have not been
mapped; consequently, it is not possible to group these clones
4 For a detailed overview of phylogeny, refer to The Tree of Life site
on the World Wide Web at http://phylogeny.arizona.edu/tree/phylogeny.
html.
FIG. 5. Expression of CKb4GT-I and CKb4GT-II in various
adult chicken tissues. Poly(A)1 RNA (5 mg) was resolved on a form-
aldehyde agarose gel and transferred to Nytran. The blot was probed
with an 830-bp 32P-labeled fragment derived from the 39-untranslated
region of CKb4GT-I clone 33A (panel A). After probe removal, the blot
was rehybridized with the 945-bp 32P-labeled fragment derived from
the 39-untranslated region of CKb4GT-II clone 25B (panel B). Each
probe was labeled to approximately the same specific activity; conse-
quently, the steady state mRNA levels in the indicated tissues are
directly comparable. RNA sizes in kb were determined relative to an
RNA ladder.
TABLE II
The intron/exon boundaries in the CKb4GT-I and CKb4GT-II genes
The intron/exon junctions of CKb4GT-I and CKb4GT-II are shown
and are compared with those established for murine (MU) b4GT. Exon
nucleotide sequence is represented by capital letters; intron sequence is
represented by lowercase letters. The superscript number refers to the
position of either the first or last nucleotide within a given exon.
CKb4GT-II Exon 0 ---GCCGCG246gaaggc
CKb4GT-I ---TGCTCG301gtgagt
MUb4GT Exon 1 ---TGCTCG gtaaga
CKb4GT-II cagcag245GATCGG--- ---GCTTAG316gtgaga
CKb4GT-I ttccag302TCGGAC--- ---AACCAG537gtaaga
MUb4GT ctctag TTGGCC--- Exon 2 ---AATCAG gtgagg
CKb4GT-II ttgcag317TCGGGC--- ---AACCAG552gtgagt
CKb4GT-I aaccag538GATGGA--- ---ATTTCG725gtgaga
MUb4GT caccag GCTGGA--- Exon 3 ---GTTTAG gtaaga
CKb4GT-II cctcag553TATGGC--- ---GTTCAG743gtgggt
CKb4GT-I ttctag726GTTACC--- ---CAACAG848gtaaag
MUb4GT ctccag CCTGCC--- Exon 4 ---TAACAG gtaatg
CKb4GT-II ctgcag744GTTGCC--- ---TAACCG866gtagtg
CKb4GT-I cggcag849GCTGGT--- ---GGAGAG953gtgcgg
MUb4GT tggcag ATTAGT--- Exon 5 ---TCAGAG gtaatg
CKb4GT-II ctccag867GATCTC--- ---GCAGAG971gtgagc
CKb4GT-I ccgcag954GTTTGA--- ---39-end
MUb4GT tggtag GTTTGA--- Exon 6 ---39-end
CKb4GT-II caccag972ATTCAC--- ---39-end
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by chromosomal assignment, as has been accomplished with
the human sequence tags. The largest subset of these clones,
based on essentially 100% sequence identity, represent the
previously cloned b4GT gene that is located at the centromeric
region of chromosome 4 (12). Among the remaining clones,
there are a number of candidate subsets that potentially cor-
respond to the human b4GT homologue located on chromosome
1p, which, based on conserved synteny, would be predicted to
map to mouse chromosome 4, approximately 50 centimorgans
from the centromere (Fig. 6B).
Do the Human and Murine b4GT Homologues Encode b4GT
Enzymatic Activity?—Two laboratories have independently re-
ported the generation of mice in which the b4GT gene has been
inactivated by homologous recombination (34, 35). The null
mice survive to term, and a significant percentage survive to
maturity and are fertile. Interestingly, both groups have re-
ported residual b4GT enzymatic activity in the range of ;5% in
several tissues including the liver, testis, and brain, when
GlcNAc (35) or asialylagalactotransferrin (34) was used as the
acceptor sugar substrate. This residual b4GT enzymatic activ-
ity invites the conclusion that one or more of the new mouse
b4GT homologues may in fact encode a b4-galactosyltrans-
ferase enzymatic activity. The enzymatic activity encoded by
each of these human and mouse b4GT homologues is currently
under investigation.
The Golgi Retention Signal: Comparison of the Transmem-
brane Domain and Flanking Sequences between Chicken and
Mammalian b4GT—The current view is that the transmem-
brane domain plays a major role in the Golgi retention of type
II membrane-bound proteins (reviewed in Refs. 36–38). For
specific Golgi-resident glycosyltransferases, the sequences
flanking the transmembrane domain may also be required for
a fully functional retention signal. Interestingly, a comparison
of the amino acid sequence of the NH2-terminal regions of a
group of resident proteins with a similar Golgi distribution has
failed to reveal a sequence motif in common that could function
as a Golgi retention signal.
An alternative approach to identifying essential amino acids
within a functional domain is to compare the primary structure
of the same protein from evolutionarily distant species. Using
this strategy, one can establish the “mutations” allowed by
nature consistent with maintenance of the functional domain.
This approach is particularly applicable for an interspecies
comparison of b4GT because the NH2-terminal region includ-
ing the lumenal stem domain (amino acids 1–92), in contrast to
the COOH-terminal catalytic domain, exhibits the greatest
divergence in primary structure (Fig. 3). Interestingly, within
this region of divergence, the transmembrane domain and the
nine amino acids of the cytoplasmic domain that immediately
flank the transmembrane domain, stand out as being highly
conserved. This point is further amplified by an inspection of
the sequence alignment of the NH2-terminal regions of the
human, bovine, murine, CKb4GT-I, and CKb4GT-II b4GT
polypeptides (Fig. 7). In the NH2-terminal flanking sequence,
four amino acids are identical and three are conservative re-
placements. Within the transmembrane domain, four amino
acids are identical and six are conservative replacements. In
contrast, the amino acids in the remainder of the cytoplasmic
domain and the lumenal sequence flanking the transmem-
brane domain are not conserved. The fact that the indicated
subset of amino acids distributed within the transmembrane
and cytoplasmic domain have remained conserved over ;250
million years of evolution suggests that they may serve as a
“functional unit” for retention of b4GT in the trans-Golgi.
Absence of the 13-Amino Acid NH2-terminal Extension in the
Chicken b4GT Homologues—Transcription of the murine b4GT
gene in somatic tissues takes place at one of two different start
sites that are separated by ;200 bp (Fig. 8). Use of these two
transcriptional start sites results in a 4.1- and a 3.9-kb mRNA.
The main difference between these two mRNAs is the length
and extent of the predicted secondary structure of the respec-
tive 59-untranslated regions (10). The 4.1-kb start site is posi-
tioned upstream of the first two in-frame ATGs, whereas the
3.9-kb start site is located between these two in-frame ATGs
(Fig. 8). Consequently, translation of the 4.1- and 3.9-kb
mRNAs results in the biosynthesis of two protein isoforms that
differ only in the length of their respective NH2-terminal cyto-
plasmic domains. The “long” and “short” b4GT protein isoforms
have NH2-terminal cytoplasmic domains of 24 and 11 amino
acids, respectively.
The functional significance of this additional 13 amino acids
has been the subject of much interest and speculation. Based
on the conclusions from a number of investigators who showed
that the transmembrane domain of b4GT is sufficient to retain
a reporter protein in the Golgi compartment (reviewed in Refs.
36–38) and our demonstration that both b4GT protein isoforms
were localized in the trans-Golgi compartment as assessed by
immunoelectron microscopy, we have concluded that both iso-
forms are functionally equivalent Golgi-resident proteins (39).
A contrasting viewpoint has been put forth by Shur and col-
leagues (40), who suggested that the 13-amino acid extension
serves a functional role by overriding the trans-Golgi retention
signal, thereby directing a small percentage or “portion” of this
isoform to the cell surface. It was posited that, at the cell
surface, the long b4GT isoform functions as a cell adhesion
molecule by virtue of its ability to interact with the cytoskele-
ton via this 13-amino acid extension (41).
FIG. 6. Chromosomal positions of the human and murine b4GT
gene, the two chicken b4GT genes, and the corresponding syn-
teny groups. A, b4GT and aconitase I map to human chromosome
9p13 (left) and to mouse chromosome 4, ;18.6 centimorgans from the
centromere (middle). The position of CKb4GT-I and the aconitase I/
IREBP gene is shown on the long arm of chicken chromosome Z (right).
The Z chromosome of birds is the sex chromosome common to males (ZZ)
and females (ZW). B, the position of RPL5 and the subset of expressed
sequence tag (est) clones on human chromosome 1p is shown (left).
The corresponding position in the mouse is predicted to be on chromo-
some 4, approximately 50 centimorgans from the centromere (middle).
Both CKb4GT-II and RPL5 have been mapped to the small chicken
chromosome 8 (right).
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In the context of the biological significance of this 13-amino
acid extension, a comparison of the cytoplasmic domains of the
mammalian and the two chicken b4GT proteins is instructive.
Since b4GT has been reported on the cell surface of a variety of
chicken cells and tissues (see Ref. 42 and references therein),
one would anticipate that a functional domain responsible for
the redirection of a protein from the Golgi to the cell surface
would be conserved between mammals and chickens.
From an inspection of the amino acid sequences of the re-
spective cytoplasmic domains, two features stand out. First,
the 13-amino acid extension characteristic of the mammalian
long b4GT protein isoform is absent in both chicken b4GT
homologues. Second, in place of this 13-amino acid extension, a
tetra- or pentapeptide is present, which with the exception of
the initiating Met, does not have any sequence in common with
the mammalian NH2-terminal extension. The lack of conserva-
tion in the amino acid sequence of the cytoplasmic domains
between the two chicken and the mammalian b4-galactosyl-
transferases needs to be taken into account when considering
the functional role for the 13-amino acid extension that distin-
guishes the long b4GT protein isoform in mammals.
In Contrast to the Murine b4GT Gene, Transcription of the
CKb4GT-I Gene Takes Place at a Single Start Site—Based on a
detailed promoter analysis of the murine b4GT gene, we have
provided a biological and functional rationale for the unusual
structure of the 59-end of this glycosyltransferase gene (Fig. 8).
Specifically, we have proposed a model of transcriptional and
translational regulation in which the region upstream of the
4.1-kb start site functions as a ubiquitous or housekeeping
promoter for glycan biosynthesis. In contrast, the region adja-
cent to the 3.9-kb start site functions primarily as a mammary
cell-specific promoter for lactose biosynthesis (10, 11). The es-
sential feature of our model is that mammals have evolved a
two-step mechanism to generate the elevated levels of b4GT
enzymatic activity, in the lactating mammary gland, that are
required for lactose biosynthesis. In step one, there is an up-
regulation of the steady state levels of b4GT mRNA, due to
increased transcription from the 3.9-kb start site. In step two,
the 3.9-kb b4GT transcript is translated more efficiently, rela-
tive to its housekeeping counterpart, due to deletion of most
(;200 nt) of the long GC-rich 59-untranslated sequence char-
acteristic of the 4.1-kb mRNA.
Based on this model, we have argued that the 3.9-kb tran-
scriptional start site and its accompanying tissue-restricted
regulatory elements have evolved in mammals to accommodate
the recruited role of b4GT for lactose biosynthesis (11). As
pointed out in the Introduction, a prediction of this model is
that, because b4GT in nonmammalian vertebrates functions
exclusively in a housekeeping (glycan biosynthesis) role, the
gene will exhibit only one (or one set of) clustered transcrip-
tional start site(s), characteristic of many housekeeping genes.
The structures of the respective 59-end of the CKb4GT-I and
the murine b4GT gene are summarized in Fig. 8. Note that in
contrast to the mammalian b4GT gene, the CKb4GT-I gene has
a single transcriptional and translational start site; conse-
quently, this prediction of our model has been substantiated. In
our view, these data support the concept that these additional
features of the mammalian b4GT gene were introduced into the
ancestral vertebrate CKb4GT-I gene lineage, during the evo-
lution of mammals, as a direct consequence of the recruitment
of this galactosyltransferase for the mammary gland-specific
biosynthesis of lactose.
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